112 related articles for article (PubMed ID: 29319143)
1. Prognostic Factors of Breast Cancer Survival in the Islamic Republic of Iran: an Additive Empirical Bayesian Approach.
Nematolahi S; Rezaianzadeh A; Zare N; Akrami M; Tahmasebi S
East Mediterr Health J; 2018 Jan; 23(11):721-728. PubMed ID: 29319143
[TBL] [Abstract][Full Text] [Related]
2. A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models.
Nematolahi S; Ayatollahi SMT
Epidemiol Health; 2017; 39():e2017043. PubMed ID: 29056033
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.
Rezaianzadeh A; Peacock J; Reidpath D; Talei A; Hosseini SV; Mehrabani D
BMC Cancer; 2009 Jun; 9():168. PubMed ID: 19497131
[TBL] [Abstract][Full Text] [Related]
5. Modeling of breast cancer prognostic factors using a parametric log-logistic model in Fars province, Southern Iran.
Zare N; Doostfatemeh M; Rezaianzadeh A
Asian Pac J Cancer Prev; 2012; 13(4):1533-7. PubMed ID: 22799361
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
[TBL] [Abstract][Full Text] [Related]
7. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).
Balslev I; Axelsson CK; Zedeler K; Rasmussen BB; Carstensen B; Mouridsen HT
Breast Cancer Res Treat; 1994; 32(3):281-90. PubMed ID: 7865856
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
Hayashi N; Takahashi Y; Matsuda N; Tsunoda H; Yoshida A; Suzuki K; Nakamura S; Yamauchi H
Clin Breast Cancer; 2018 Apr; 18(2):e219-e229. PubMed ID: 29138067
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of survival time of breast cancer in kurdistan province of Iran between 2006-2014: a cox regression approach.
Karimi A; Delpisheh A; Sayehmiri K; Saboori H; Rahimi E
Asian Pac J Cancer Prev; 2014; 15(19):8483-8. PubMed ID: 25339051
[TBL] [Abstract][Full Text] [Related]
10. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
[TBL] [Abstract][Full Text] [Related]
11. Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer.
Masarwah A; Auvinen P; Sudah M; Dabravolskaite V; Arponen O; Sutela A; Oikari S; Kosma VM; Vanninen R
BMC Cancer; 2016 Nov; 16(1):833. PubMed ID: 27806715
[TBL] [Abstract][Full Text] [Related]
12. Prognostic analysis of survival in small breast cancers.
Mustafa IA; Cole B; Wanebo HJ; Bland KI; Chang HR
J Am Coll Surg; 1998 May; 186(5):562-9. PubMed ID: 9583697
[TBL] [Abstract][Full Text] [Related]
13. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
14. Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program.
Schwartz AM; Henson DE; Chen D; Rajamarthandan S
Arch Pathol Lab Med; 2014 Aug; 138(8):1048-52. PubMed ID: 25076293
[TBL] [Abstract][Full Text] [Related]
15. An overview of prognostic factors for long-term survivors of breast cancer.
Soerjomataram I; Louwman MW; Ribot JG; Roukema JA; Coebergh JW
Breast Cancer Res Treat; 2008 Feb; 107(3):309-30. PubMed ID: 17377838
[TBL] [Abstract][Full Text] [Related]
16. Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group.
Sundquist M; Thorstenson S; Brudin L; Nordenskjöld B
Breast Cancer Res Treat; 1999 Jan; 53(1):1-8. PubMed ID: 10206067
[TBL] [Abstract][Full Text] [Related]
17. Impact of age, tumor size, lymph node metastasis, stage, receptor status and menopausal status on overall survival of breast cancer patients in Pakistan.
Mahmood H; Faheem M; Mahmood S; Sadiq M; Irfan J
Asian Pac J Cancer Prev; 2015; 16(3):1019-24. PubMed ID: 25735323
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
[TBL] [Abstract][Full Text] [Related]
19. Factors Affecting Long-Survival of Patients with Breast Cancer by Non-Mixture and Mixture Cure Models Using the Weibull, Log-logistic and Dagum Distributions: A Bayesian Approach.
Rafati S; Baneshi MR; Bahrampour A
Asian Pac J Cancer Prev; 2020 Feb; 21(2):485-490. PubMed ID: 32102528
[TBL] [Abstract][Full Text] [Related]
20. Vascular invasion as an independent prognostic factor in lymph node negative invasive breast cancer.
Rezaianzadeh A; Talei A; Rajaeefard A; Hasanzadeh J; Tabatabai H; Tahmasebi S; Mousavizadeh A
Asian Pac J Cancer Prev; 2012; 13(11):5767-72. PubMed ID: 23317254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
